Lead Product(s) : S-Equol
Therapeutic Area : Obstetrics/Gynecology (Women’s Health)
Study Phase : Undisclosed
Sponsor : Biofortis Mérieux Nutriscience
Deal Size : Inapplicable
Deal Type : Inapplicable
A Nutritional Supplement on Vasomotor Symptoms in Women
Details : S-equol is a Dietary Supplement drug candidate, which is currently being evaluated in clinical studies for the treatment of Menopause.
Product Name : Undisclosed
Product Type : Dietary Supplement
Upfront Cash : Inapplicable
August 18, 2020
Lead Product(s) : S-Equol
Therapeutic Area : Obstetrics/Gynecology (Women’s Health)
Highest Development Status : Undisclosed
Sponsor : Biofortis Mérieux Nutriscience
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : S-Equol
Therapeutic Area : Neurology
Study Phase : Phase I/ Phase II
Sponsor : Ausio Pharmaceuticals
Deal Size : Inapplicable
Deal Type : Inapplicable
S-Equol in Alzheimer's Disease 2 Trial
Details : S-equol is a Dietary Supplement drug candidate, which is currently being evaluated in phase I/ phase II clinical studies for the treatment of Alzheimer Disease.
Product Name : Undisclosed
Product Type : Dietary Supplement
Upfront Cash : Inapplicable
April 04, 2017
Lead Product(s) : S-Equol
Therapeutic Area : Neurology
Highest Development Status : Phase I/ Phase II
Sponsor : Ausio Pharmaceuticals
Deal Size : Inapplicable
Deal Type : Inapplicable
S-Equol in Alzheimer's Disease (SEAD) Trial
Details : AUS-131 is a Other Small Molecule drug candidate, which is currently being evaluated in phase I clinical studies for the treatment of Alzheimer Disease.
Product Name : Undisclosed
Product Type : Dietary Supplement
Upfront Cash : Inapplicable
May 20, 2014